医学
内科学
癌症
中止
危险系数
比例危险模型
肿瘤科
队列
生物标志物
胃肠病学
置信区间
生物化学
化学
作者
Senaka Peter,Răzvan Cristescu,Carol E. Peña,Angela Watkins,Carin R. Espenschied,Nicole Zhang,Jiemin Liao
摘要
We used RWD to demonstrate that high pretreatment ctDNA burden was associated with worse clinical outcomes in a mGC population receiving 1L chemotherapy-based treatments. Our analysis suggests ctDNA burden could be used as a prognostic biomarker for mGC.
科研通智能强力驱动
Strongly Powered by AbleSci AI